Abstract

Ketamine 50-mg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2013 - Volume 17, Number 4

Page(s): 331

Download in electronic PDF format for $75
  • Ketamine 50-mg/mL Injection Page 1

Note: Electronic version includes errata or revisions.

Abstract

A formulation for preparing Ketamine 50-mg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • ketamine
  • compounded sterile preparations
  • anesthesia
  • anesthetic
  • pain relief
  • analgesia
  • analgesic

Related Categories

  • FORMULATIONS
  • PAIN MANAGEMENT
  • PARENTERALS
  • STERILE PREPARATIONS
  • SURGERY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2013
Pg. 331
Ketamine 50-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 107-113
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Author(s): Rabi Joseph
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 172-175
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome
Author(s): Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
Jul/Aug 2000
Pg. 253-254
Ketamine for Pain in Hospice Patients
Author(s): Wood Robert M
Nov/Dec 2016
Pg. 517-520
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Author(s): Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Sep/Oct 2012
Pg. 364-368
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report
Author(s): McNulty Jack P, Hahn Kristian
Jul/Aug 2015
Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024
Pg. 111-116
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Sep/Oct 2012
Pg. 423
Meperidine Hydrochloride 50-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2010
Pg. 512
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 424-430
Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model
Author(s): Baneshi Marzieh, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X
May/Jun 2008
Pg. 192-197
Compounded Local Anesthetics to Minimize Pain from Medical Procedures
Author(s): McElhiney Linda F
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024
Pg. 100-109
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Nov/Dec 2007
Pg. 514-519
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen
Author(s): Zugerman Jessie Jean M, Reed Thomas C
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
May/Jun 2019
Pg. 221-228
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Author(s): Allen Loyd V Jr